Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by canadafanon Mar 12, 2024 2:49pm
143 Views
Post# 35928966

RE:Volume

RE:Volume

Looks like the Canadian market went to sleep today.
the Nas Oncy , not exactly blazing an6 trading trails either.
There are many shares outstanding. Meaning being held.
One can interpret the low volume 2 ways. 

No buyer interests & equally no seller interest.....at existing price points.
Hard concept to grasp. 

Essentially tye 1000s of existing shareholders are saying ":I'm willing to wait & see what happens next, not selling at these prices"
and
The many hundreds of potential new buyers are saying ":I'm willing to wait & see what happens next, I'm not buying at any price"
IMHO a very interesting spot to be in.
For me, I'm not selling @ any shares until news of a partnership or buyout.
So, the solitude of trading volume is a nice backdrop.

A bit if deeper analysis regarding this type of near zero activity.
Any good news at all will be met with a substantial SP increase.
The Q4 update did contain some opportunities for future excitement. Yet the delivery left a lot to be found.
Meaning one had to listen between the lines.
it was acknowledged that they plan on starting phase 3 this year. With details to follow soon.
also updates on bracelet overall survival due, when the events happen.
So, lots of wait & see type of things.
seems to be the " market" is in the wait & see mode.
I appreciate hard to get excited in the backdrop of low volume & near all time low prices.
afterall, yiu can always wait until there is excitement & pay 10% more.
Funny side story on that.
Back when we had the panic/ Covid correction, some mutual funds pro they would not touch Ford , under $10....their portfolio mandate was not to buy anything under $10.
Yet were quite happy to by buy above $15!
call me crazy! 

one would do better buying when others are not.
Other interesting tid bit for today.
ever notice the fudster crew ONLY post when market is open. Never on weekends.
By observation, They work real hard to keep up the FUD. 

The evidence speaks for itself.
 

 

<< Previous
Bullboard Posts
Next >>